ArticleCase reports in oncology

Exceptional Response to Lenvatinib plus Pembrolizumab after Pembrolizumab Failure in MLH1-Methylated Deficient Mismatch Repair/Microsatellite Instability-High Endometrial Cancer: A Case Report.

Natsuko Kamiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.